Method of use of an embolic implant for radio-ablative treatment

Patent metadata

Field	Value
Publication number	US-10232191-B2
Application number	US-201715635258-A
Country	US
Kind code	B2
Filing date	Jun 28, 2017
Priority date	Apr 24, 2014
Publication date	Mar 19, 2019
Grant date	Mar 19, 2019

Abstract

A method of radio-ablation in conjunction with embolic implants used for pre-embolization of branch arteries in radio-ablation of the liver or other diseased tissue.

First claim

We claim:

1. A method comprising:
implanting an embolic implant in vasculature of a patient at a site proximal to a diseased region of tissue within the patient, wherein the diseased region is proximate healthy tissue or organs, and wherein the diseased region is supplied with blood through a main artery of the vasculature, and the healthy tissue or organs is supplied with blood through a branch artery of the main artery, the embolic implant comprising a wire-frame structure and a membrane covering at least one end of the wire-frame structure, wherein the membrane substantially blocks blood from flowing through the at least one end of the wire-frame structure in a direction of blood flow through the vasculature when the implant is deployed in the vasculature; and
depositing an ablative substance in the main artery distal to the embolic implant site.

2. The method of claim 1 , wherein implanting the embolic implant in the vasculature comprises implanting the embolic implant in the branch artery before depositing the ablative substance, wherein substantially complete occlusion of the branch artery and substantially complete stoppage of blood flow in the branch artery is achieved in less than 5 minutes from implantation of the embolic implant in the branch artery.

3. The method of claim 1 , wherein implanting the embolic implant in the vasculature comprises implanting the embolic implant in the branch artery after depositing the ablative substance.

4. The method of claim 1 , wherein implanting the embolic implant in the vasculature comprises implanting the embolic implant in the main artery, distal to the branch artery, before depositing the ablative substance, the method further comprising:
navigating a catheter into the main artery, and navigating a distal segment of the catheter past the embolic implant;
delivering the ablative substance through the catheter to deposit the ablative substance distal to the embolic implant; and
withdrawing the catheter from the main artery.

5. The method of claim 4 , further comprising removing the embolic implant from the main artery after deposition of the ablative substance.

6. The method of claim 1 , wherein implanting the embolic implant in the vasculature comprises implanting the embolic implant in the main artery, distal to the branch artery, after depositing the ablative substance.

7. The method of claim 1 , wherein the ablative substance comprises microspheres, liposomes, macromolecules, or vesicles.

8. The method of claim 1 , wherein the ablative substance comprises a radioactive element.

9. The method of claim 1 , wherein the ablative substance is a radioembolic sub stance.

10. The method of claim 1 , wherein the ablative substance is a non-embolic radio-ablative substance.

11. The method of claim 1 , wherein the wire-frame structure comprises:
a pair of opposing zigzag segments including a plurality of V-shaped elements defining an open end, the V-shaped elements joined at the open end of the V-shaped elements, the V-shaped elements defining proximal or distal vertices pointing proximally or distally away from a center of the wire-frame structure; and
a plurality of longitudinally oriented struts extending from the proximally or distally pointing vertices of the V-shaped elements, the longitudinally oriented struts being joined together near a radial center of the wire-frame structure at one end of the embolic implant, wherein the wire-frame structure is formed of a self-expanding material.

12. The method of claim 1 , wherein the embolic implant includes a proximal end and a distal end, the wire-frame structure comprising:
a pair of opposing zigzag segments including a plurality of V-shaped elements defining an open end, the V-shaped elements joined at the open end of the V-shaped elements via short longitudinally aligned struts to form a central portion of the wire-frame structure, the short struts being longitudinally displaced from each other, the V-shaped elements defining proximal or distal vertices pointing proximally or distally away from a center of the wire-frame structure;
a plurality of longitudinally oriented struts extending from the proximally pointing vertices of the V-shaped elements, the longitudinally oriented struts being joined together near a radial center of the wire-frame structure at the proximal end of the embolic implant, wherein the wire-frame structure is formed of a self-expanding material; and
the membrane disposed over the proximal end of the embolic implant, the membrane having a proximal facing surface, the membrane being impermeable to blood on the proximal facing surface.

13. A method for radio-ablative treatment of a liver of a patient, the method comprising:
implanting an embolic implant in vasculature of the patient at a site proximal to the liver of the patient, wherein the liver is proximate at least one other organ, wherein the liver is supplied with blood through a hepatic artery of the vasculature, and the at least one other organ is supplied with blood through an extra-hepatic branch artery of the hepatic artery, the embolic implant comprising a wire-frame structure and a membrane covering at least one end of the wire-frame structure, wherein the membrane substantially blocks blood from flowing through the at least one end of the wire-frame structure in a direction of blood flow through the vasculature when the embolic implant is deployed in the vasculature; and
depositing an ablative substance in the hepatic artery distal to the embolic implant site.

14. The method of claim 13 , wherein implanting the embolic implant in the vasculature comprises implanting the embolic implant in the extra-hepatic branch artery before depositing the ablative substance, wherein substantially complete occlusion of the extra-hepatic branch artery and substantially complete stoppage of blood flow in the extra-hepatic branch artery, is achieved in less than 5 minutes from implantation of the embolic implant in the extra-hepatic branch artery.

15. The method of claim 13 , wherein implanting the embolic implant in the vasculature comprises implanting the embolic implant in the extra-hepatic branch artery after depositing the ablative substance.

16. The method of claim 13 , wherein implanting the embolic implant in the vasculature comprises implanting the embolic implant in the hepatic artery, distal to the extra-hepatic branch artery, before depositing the ablative substance, the method further comprising:
navigating a catheter into the hepatic artery, and navigating a distal segment of the catheter past the embolic implant;
delivering the ablative substance through the catheter to deposit the ablative substance distal to the embolic implant; and
withdrawing the catheter from the hepatic artery.

17. The method of claim 13 , wherein implanting the embolic implant in the vasculature comprises implanting the embolic implant in the hepatic artery, distal to the extra-hepatic branch artery after depositing the ablative substance.

18. The method of claim 13 , wherein the ablative substance comprises a radioactive element.

19. The method of claim 13 , wherein the ablative substance is a radioembolic sub stance.

20. The method of claim 13 , wherein the ablative substance is a non-embolic radio-ablative substance.

21. The method of claim 13 , wherein the wire-frame structure comprises:
a pair of opposing zigzag segments including a plurality of V-shaped elements defining an open end, the V-shaped elements joined at the open end of th

Assignees

• Covidien Lp

Inventors

• Strauss Brian M
• Valko Jeffrey J

Classifications

• A61N5/1002 Primary

  Intraluminal radiation therapy · CPC title

• A61B2017/00942

  hydrophilic · CPC title

• A61B17/12186

  liquid materials adapted to be injected · CPC title

• A61B2018/00577

  Ablation · CPC title

• A61N2005/1021

  Radioactive fluid · CPC title